Key details for this exam, checked against the published exam outline
Each question shows the correct answer and an explanation of why it is right
Which statement applies to the CRF Completion Guidelines (CCGs) for a multinational study?
The Case Report Form (CRF) Completion Guidelines (CCGs) are critical documents that guide site staff on how to accurately and consistently record data on CRFs across all participating sites, especially in multinational trials.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: CRF Design and Data Collection), one of the key components of the CCGs is a list of acceptable abbreviations and conventions to be used during CRF entry. This standardization ensures data consistency across languages and countries, reduces ambiguity during data review, and facilitates database design and coding accuracy.
While translation (A) may be useful for training materials, it is not required for CCGs unless specified by regulatory bodies. Options C and D are incorrect because data collection should adhere to standardized terms in English (or the study's official language) --- allowing free use of local languages or arbitrary abbreviations introduces inconsistencies.
Hence, option B --- ''CCGs must contain the list of acceptable abbreviations to be used in the CRF'' --- is correct.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: CRF Design and Data Collection, Section 5.3 -- CRF Completion Guidelines and Standardization
ICH E6(R2) GCP, Section 5.5.3 -- Consistency and Data Recording Requirements
FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.2 -- Data Entry Conventions and Documentation
Which method would best identify inaccuracies in safety data tables for an NDA?
The best method for identifying inaccuracies in safety data tables prepared for a New Drug Application (NDA) is to compare counts of appropriate patients from line listings of CRF data to the counts in table cells.
According to the GCDMP (Chapter: Data Quality Assurance and Control), line listings represent raw, patient-level data extracted directly from the clinical database, whereas summary tables are aggregated outputs used for reporting and submission. Comparing these two sources ensures data traceability and accuracy, verifying that tabulated results correctly reflect the underlying patient data.
Manual CRF checks (option A) are less efficient and error-prone, as data entry is typically already validated electronically. Simply reviewing tables or listings for ''odd values'' (options C and D) lacks the systematic verification necessary for regulatory data integrity.
Thus, comparing line listings to tables (option B) provides a quantitative cross-check between the database and output deliverables, a standard practice in NDA data validation and statistical quality control.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 5.2 -- Validation of Tables, Listings, and Figures (TLFs)
FDA Guidance for Industry: Submission of NDA Safety Data, Section on Data Verification and Accuracy
ICH E6 (R2) GCP, Section 5.5.3 -- Validation of Derived Data Outputs
A study team member states that data entry can be done by clerical personnel at sites. Which are important considerations?
Although clerical staff can technically perform data entry, data entry in clinical research requires study-specific training, particularly in the use of the Electronic Data Capture (EDC) system and understanding data discrepancy resolution procedures.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: CRF Design and Data Collection) and ICH E6 (R2), individuals responsible for data entry at clinical sites must be qualified by education, training, and experience. This includes understanding how to navigate the EDC system, enter data according to CRF Completion Guidelines, and appropriately respond to queries or system-generated edit checks.
Untrained clerical personnel may inadvertently introduce errors, violate Good Clinical Practice (GCP) standards, or fail to recognize protocol-relevant data. Therefore, the Data Manager must ensure that site users receive study-specific and system training before gaining access to the EDC environment.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 5.2 -- Investigator Site Training and Data Entry Requirements
ICH E6 (R2) Good Clinical Practice, Section 4.1.5 -- Qualified Personnel and Training Requirements
FDA 21 CFR Part 11 -- User Access and Training Provisions for Electronic Records
All range and logic checks have been resolved in a study. An auditor found discrepancies between the database and the source. Which reason is most likely?
Even when all range and logic checks are successfully resolved, discrepancies may still exist between the clinical database and the source documents. This typically indicates an error in data abstraction or transcription, meaning that data were incorrectly entered or extracted from the source records during the data entry or verification process.
According to the Good Clinical Data Management Practices (GCDMP, Chapter on Data Validation and Cleaning), data validation rules such as range and logic checks are designed to identify inconsistencies, missing data, or out-of-range values within the database itself. However, they do not verify the accuracy of data entry against the original source documents --- that responsibility falls under source data verification (SDV), typically conducted by clinical monitors or auditors.
When an auditor detects discrepancies between source and database values after all edit checks have passed, the most probable explanation is that data were not transcribed correctly from the source, rather than a failure in programmed edit checks. This could occur due to human error during manual data entry, misinterpretation of the source document, or oversight during SDV.
Option C (Data were changed after checks were run) might occur in rare cases but would normally be documented in an audit trail per 21 CFR Part 11 and ICH E6 (R2) standards. Option B misinterprets the issue, since ''logical and in range'' values can still be incorrect relative to the source. Option A (Auditor error) is possible but statistically less likely, as source data verification follows strict, documented audit procedures.
Therefore, the most likely reason for such discrepancies is Option D: Data were not abstracted correctly from the source, emphasizing the importance of robust data entry training, dual data entry, and verification procedures.
Reference (CCDM-Verified Sources):
Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 6.5 -- Source Data Verification and Reconciliation
ICH E6 (R2) Good Clinical Practice, Section 5.18 -- Monitoring and Source Data Verification
FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6 -- Source Data Accuracy and Audit Trails
21 CFR Part 11 -- Electronic Records and Electronic Signatures, Subpart B: Audit Trails and Record Accuracy
Which Clinical Study Report section would be most useful for a Data Manager to review?
The section of the Clinical Study Report (CSR) most useful for a Data Manager is the description of how data were processed.
According to the GCDMP (Chapter: Data Quality Assurance and Control), this section details the data handling methodology --- including data cleaning, coding, transformation, and derivation procedures --- all of which are core responsibilities of data management. Reviewing this section ensures that the data processing methods documented in the CSR align with the Data Management Plan (DMP), Data Validation Plan (DVP), and database specifications.
The statistical methods section (option A) is primarily for biostatistics, and the rationale for study design (option B) pertains to clinical and regulatory affairs. Clinical narratives (option D) are used by medical reviewers, not data managers.
By reviewing how data were processed, the Data Manager verifies that the study data lifecycle---from collection to analysis---was conducted in compliance with regulatory and GCDMP standards.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 6.3 -- Documentation of Data Processing in Clinical Study Reports
ICH E3 -- Structure and Content of Clinical Study Reports, Section 11.3 -- Data Handling and Processing
FDA Guidance for Industry: Clinical Study Reports and Data Submission -- Data Traceability and Handling Documentation
150 questions covering all exam domains, starting from $20
Exam domains verified against: Official SCDM CCDM exam guide, last checked September 2026.
Plan and construct the technical infrastructure for a clinical study. This includes identifying what data to collect, defining data elements, designing case report forms and their completion guidelines, annotating forms, designing workflows and data flows, writing procedures that support auditability, maintaining data management plans, specifying database tables and entry screens, defining edit checks and reports, and writing data transfer specifications. You will also select, implement, and manage data standards, and respond to audit findings.
Sample question from this domain above: Q1
Educate cross-functional teams and spread knowledge of data management processes across the organization. This covers designing and delivering training that follows instructional design principles and evaluating its effectiveness. The goal is to build shared understanding of data management best practices throughout your study team and wider organization.
Sample question from this domain above: Q3
Manage the day-to-day flow and quality of study data from collection through archive. This includes collecting and entering data, importing and exporting information between systems, linking data from different sources, reconciling externally sourced data, transforming and coding data, identifying discrepancies, querying sites to resolve issues, updating the database, measuring data quality, and applying analytics to spot problems and opportunities. You also manage system access and archive or share study data.
Sample question from this domain above: Q4
Build and run comprehensive tests to verify the data system works as designed. You will draft test plans and test data for database tables, user interfaces, workflows, reports, and data transformations. Testing covers system validation, user acceptance, and usability. After testing, you execute the tests, document the results, and track any issues discovered.
Direct and oversee the work of clinical data managers, data processing staff, and computer programmers. This involves assigning work, monitoring quality, providing feedback, and ensuring the team has the guidance and resources needed to complete data management activities on schedule and to specification.
Lead the operational side of data management on a study. You will define the scope of work, select and manage vendors, estimate workload and manage timelines, coordinate the start of data management activities, oversee data collection and processing, lock the database when complete, track data metrics, identify and manage risk, prepare for audits, plan and run project meetings, and maintain the project communication plan.
Check and validate data and documentation to catch errors before they propagate. You will review study documents like protocols and consent forms to identify what impact they have on data collection, review data in tables, listings, and figures as well as clinical study reports for accuracy and proper documentation of data handling, and review the work of junior data managers and processors.
Common questions about the exam itself
